Synchron

We’re excited to announce the launch of our community-centered BCI registry to bring patients, carers and clinicians together to learn how #BCI is being designed to provide benefit to people with limited mobility. 🧠🧠 “We are thrilled to launch our community-centered BCI registry,” said Thomas Oxley, CEO & Founder, Synchron. “There is a grass roots movement happening with BCI. We are creating an avenue for potential users and their physicians to engage and stay connected while we prepare for the next stage of clinical trials.” Read the release: 👇👇 https://lnkd.in/enXKFMTb #neurotech #braincomputerinterface #clinicaltrials #patients

Freethink spoke with our CTO Riki Banerjee about how we’re tapping into the brain without open-brain surgery. 🧠🧠 “When BCIs pop up in the popular media, it’s often in connection to Elon Musk’s Neuralink. But Synchron may be ahead of the game in some respects. The company was founded four years earlier than its chief competitor, in 2012, has received investments from Bill Gates and Jeff Bezos, and has already launched two trials – one in Australia, another in the US. The company’s key advantage over Neuralink, which took on its first human patient earlier this year, is that its BCIs do not require brain surgery. Where Neuralink implants its interfaces directly into the cerebral cortex, Synchron implants its devices through the patient’s bloodstream, circumventing the cost and risks of physically penetrating the human skull.” Read the article: 👇👇 https://lnkd.in/d4u6D5c8

Sharing a recap of our fireside chat at the LSI 2024 Emerging Medtech Summit. The fireside chat featured our CEO & Founder Thomas Oxley and Andy Rasdal, with moderator Kimberly Ha at KKH Advisors. Thanks LSI for inviting us! #BCI #neurotechnology #pioneers

Brain-computer startup Synchron has set out to help paralyzed patients communicate with the world by implanting a device called the "stentrode" into their brains. More on Posthuman with Emily Chang: https://trib.al/GVMWJUO

In the latest from Bloomberg Originals, Emily Chang explores how #neurotechnology is transforming lives. Meet Rodney, one of our earliest users, who shows us how to communicate using a brain-computer interface (#BCI), and hear our CEO, Thomas Oxley share how this technology works and his vision for the future. Watch the episode here: https://lnkd.in/eq83abY2

Sharing our CEO Thomas Oxley’s fireside chat at Forbes CIO Summit about #BCIs with Alex Knapp. 🧠🧠 Watch the replay here: https://lnkd.in/eZjba3mF

"We are developing an implantable brain computer interface... It's really life changing for these patients." Synchron CEO Thomas Oxley spoke about the work his company is doing with Forbes senior editor Alex Knapp at the 2024 #ForbesCIO Summit in New York City. https://lnkd.in/eS_Mtt9P

We’re excited to share that our CEO, Thomas Oxley, will be speaking at the #ForbesCIO Conference! Tom will join Forbes Senior Editor Alex Knapp for an insightful discussion focusing on the patient experience with brain-computer interface (BCI) technology. 🗓 Date: 4:10pm EST 📍 Location: NYC and Virtual Join us as they explore how #BCI could improve independence, autonomy and privacy for patients with paralysis. Learn more here: https://lnkd.in/gkCpU8qn

Congratulations to our CTO Riki Banerjee on being nominated to Fierce Biotech's 2024 Fiercest Women in Life Sciences. At Synchron, a Fierce 15 and Fierce 50 honoree, Banerjee has been working with an international team to devise world-first clinical studies. The goal is not only to show that the company’s approach can improve a person’s life but also to quantify the idea of a person’s ability to act more autonomously. “In that context, we’ve been looking at the framework of occupational therapy, which also has therapists that work with a population of severely paralyzed patients,” she said. “We’ve been learning about that existing framework, but we’re also building something new into that.” Read the article for more about 10 of the most remarkable women in life sci, all of whom are redefining what it means to be truly fierce: https://lnkd.in/gciripAB

Synchron is 5 years into clinical trials implanting chips in people's brains. The technical term for these brain chips is brain-computer interface or BCI. At #FortuneGlobalForum Synchron CEO Thomas Oxley said the tech is currently being used to address paralysis. "The initial application for this technology is in the need for people who have paralysis. We anticipate this is going to be a very large area of medical device that has not yet been addressed," he said. "There's a prediction that this first-generation health care term is going to be in the range of $400 billion." So far, "the problem with open brain surgery is that none has scaled up," he added. But the company has plans to address that. More: https://lnkd.in/eRty7RrA